Joyce Pak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joyce Pak has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Jennifer L. Lund
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
9 shared publications - Bradford E. Jackson
University of North Carolina at Chapel Hill 2 Chapel Hill
7 shared publications - Jillian L. Evans-Strong
University of North Carolina at Chapel Hill 1 Department of Epidemiology Chapel Hill, North Carolina
6 shared publications - Katherine Elizabeth Reeder-Hayes
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
6 shared publications - Lawrence S. Engel
Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
6 shared publications - Miyuki Hino
University of North Carolina at Chapel Hill 3 Environment, Ecology and Energy Program Chapel Hill, North Carolina
6 shared publications
Latest Publications
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Table S3 from Impacts of Hurricane-Related Flooding on Time to Initial Cancer-Directed Treatment in North Carolina
Supplementary Table S3 presents hurricane-specific counts of exposed and unexposed patients by cancer type and study period.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Impacts of Hurricane-Related Flooding on Time to Initial Cancer-Directed Treatment in North Carolina
Supplementary Table S3 presents hurricane-specific counts of exposed and unexposed patients by cancer type and study period.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Table S1 from Impacts of Hurricane-Related Flooding on Time to Initial Cancer-Directed Treatment in North Carolina
Supplementary Table S1 presents the controlled interrupted time series (CITS) model specification and definitions of model parameters used in the analysis.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Impacts of Hurricane-Related Flooding on Time to Initial Cancer-Directed Treatment in North Carolina
Supplementary Table S1 presents the controlled interrupted time series (CITS) model specification and definitions of model parameters used in the analysis.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Impacts of Hurricane-Related Flooding on Time to Initial Cancer-Directed Treatment in North Carolina
Supplementary Figure S1 shows the aligned timelines for Hurricanes Matthew and Florence used to define pre- and post-exposure periods.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Impacts of Hurricane-Related Flooding on Time to Initial Cancer-Directed Treatment in North Carolina
Supplementary Figure S1 shows the aligned timelines for Hurricanes Matthew and Florence used to define pre- and post-exposure periods.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from Impacts of Hurricane-Related Flooding on Time to Initial Cancer-Directed Treatment in North Carolina
Supplementary Table S2 shows the association between hurricane exposure and median time to treatment by cancer type, including immediate (β6) and sustained (β7) effects.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Impacts of Hurricane-Related Flooding on Time to Initial Cancer-Directed Treatment in North Carolina
Supplementary Table S2 shows the association between hurricane exposure and median time to treatment by cancer type, including immediate (β6) and sustained (β7) effects.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Data from Impacts of Hurricane-Related Flooding on Time to Initial Cancer-Directed Treatment in North Carolina
Background:Hurricanes can disrupt healthcare delivery and patients’ access to timely cancer care. Such disruptions may contribute to adverse cancer outcomes, yet few studies have examined hurricane-related delays in treatment initiation.Methods:We conducted a quasi-experimental, observational study using a controlled interrupted time series to evaluate the association between hurricane exposure and time to initial treatment among patients diagnosed with breast, colorectal, or lung cancer in North Carolina (NC) following Hurricanes Matthew (2016) and Florence (2018). The analysis included 59,406 patients between November 2015 and August 2019 in the NC Central Cancer Registry. Hurricane-exposed areas were defined using (i) presidential disaster declarations (county level) and (ii) flood extent data [Flood Extents Archive ((FLDEX)] at county and ZIP-code levels. The monthly median time to initial cancer-directed treatment within 12 months of diagnosis was modeled using AutoRegressive Integrated Moving Average (ARIMA) to estimate immediate (level) and sustained (trend) effects.Results:No significant immediate or sustained changes in the median time to treatment were observed using Federal Emergency Management Agency–based exposure definitions. However, using ZIP code–level FLDEX data, patients with colorectal cancer in high-flood exposure areas (≥0.1% and ≥0.5% flooded) experienced significant immediate median delays of 10.39 [95% confidence interval (CI) = 2.8–18] and 10.97 days (95% CI = 2.1–19.9), respectively.Conclusions:Although no significant effects on time to treatment were observed using traditional measures of hurricane hazards, more granular flood extent data revealed treatment delays among patients with colorectal cancer living in areas with greater flooding extent.Impact:These findings provide support for further investigation of the use of ZIP code–level flood extent data to evaluate hurricane impacts on continuity of cancer care.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Impacts of Hurricane-Related Flooding on Time to Initial Cancer-Directed Treatment in North Carolina
Background:Hurricanes can disrupt healthcare delivery and patients’ access to timely cancer care. Such disruptions may contribute to adverse cancer outcomes, yet few studies have examined hurricane-related delays in treatment initiation.Methods:We conducted a quasi-experimental, observational study using a controlled interrupted time series to evaluate the association between hurricane exposure and time to initial treatment among patients diagnosed with breast, colorectal, or lung cancer in North Carolina (NC) following Hurricanes Matthew (2016) and Florence (2018). The analysis included 59,406 patients between November 2015 and August 2019 in the NC Central Cancer Registry. Hurricane-exposed areas were defined using (i) presidential disaster declarations (county level) and (ii) flood extent data [Flood Extents Archive ((FLDEX)] at county and ZIP-code levels. The monthly median time to initial cancer-directed treatment within 12 months of diagnosis was modeled using AutoRegressive Integrated Moving Average (ARIMA) to estimate immediate (level) and sustained (trend) effects.Results:No significant immediate or sustained changes in the median time to treatment were observed using Federal Emergency Management Agency–based exposure definitions. However, using ZIP code–level FLDEX data, patients with colorectal cancer in high-flood exposure areas (≥0.1% and ≥0.5% flooded) experienced significant immediate median delays of 10.39 [95% confidence interval (CI) = 2.8–18] and 10.97 days (95% CI = 2.1–19.9), respectively.Conclusions:Although no significant effects on time to treatment were observed using traditional measures of hurricane hazards, more granular flood extent data revealed treatment delays among patients with colorectal cancer living in areas with greater flooding extent.Impact:These findings provide support for further investigation of the use of ZIP code–level flood extent data to evaluate hurricane impacts on continuity of cancer care.
- 9 April 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (6) , 943-952
Impacts of Hurricane-Related Flooding on Time to Initial Cancer-Directed Treatment in North Carolina
Background: Hurricanes can disrupt healthcare delivery and patients’ access to timely cancer care. Such disruptions may contribute to adverse cancer outcomes, yet few studies have examined hurricane-related delays in treatment initiation. Methods: We conducted a quasi-experimental, observational study using a controlled interrupted time series to evaluate the association between hurricane exposure and time to initial treatment among patients diagnosed with breast, colorectal, or lung cancer in North Carolina (NC) following Hurricanes Matthew (2016) and Florence (2018). The analysis included 59,406 patients between November 2015 and August 2019 in the NC Central Cancer Registry. Hurricane-exposed areas were defined using (i) presidential disaster declarations (county level) and (ii) flood extent data [Flood Extents Archive ((FLDEX)] at county and ZIP-code levels. The monthly median time to initial cancer-directed treatment within 12 months of diagnosis was modeled using AutoRegressive Integrated Moving Average (ARIMA) to estimate immediate (level) and sustained (trend) effects. Results: No significant immediate or sustained changes in the median time to treatment were observed using Federal Emergency Management Agency–based exposure definitions. However, using ZIP code–level FLDEX data, patients with colorectal cancer in high-flood exposure areas (≥0.1% and ≥0.5% flooded) experienced significant immediate median delays of 10.39 [95% confidence interval (CI) = 2.8–18] and 10.97 days (95% CI = 2.1–19.9), respectively. Conclusions: Although no significant effects on time to treatment were observed using traditional measures of hurricane hazards, more granular flood extent data revealed treatment delays among patients with colorectal cancer living in areas with greater flooding extent. Impact: These findings provide support for further investigation of the use of ZIP code–level flood extent data to evaluate hurricane impacts on continuity of cancer care.
- 9 April 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (6) , 943-952
Impacts of Hurricane-Related Flooding on Time to Initial Cancer-Directed Treatment in North Carolina
Background: Hurricanes can disrupt healthcare delivery and patients’ access to timely cancer care. Such disruptions may contribute to adverse cancer outcomes, yet few studies have examined hurricane-related delays in treatment initiation. Methods: We conducted a quasi-experimental, observational study using a controlled interrupted time series to evaluate the association between hurricane exposure and time to initial treatment among patients diagnosed with breast, colorectal, or lung cancer in North Carolina (NC) following Hurricanes Matthew (2016) and Florence (2018). The analysis included 59,406 patients between November 2015 and August 2019 in the NC Central Cancer Registry. Hurricane-exposed areas were defined using (i) presidential disaster declarations (county level) and (ii) flood extent data [Flood Extents Archive ((FLDEX)] at county and ZIP-code levels. The monthly median time to initial cancer-directed treatment within 12 months of diagnosis was modeled using AutoRegressive Integrated Moving Average (ARIMA) to estimate immediate (level) and sustained (trend) effects. Results: No significant immediate or sustained changes in the median time to treatment were observed using Federal Emergency Management Agency–based exposure definitions. However, using ZIP code–level FLDEX data, patients with colorectal cancer in high-flood exposure areas (≥0.1% and ≥0.5% flooded) experienced significant immediate median delays of 10.39 [95% confidence interval (CI) = 2.8–18] and 10.97 days (95% CI = 2.1–19.9), respectively. Conclusions: Although no significant effects on time to treatment were observed using traditional measures of hurricane hazards, more granular flood extent data revealed treatment delays among patients with colorectal cancer living in areas with greater flooding extent. Impact: These findings provide support for further investigation of the use of ZIP code–level flood extent data to evaluate hurricane impacts on continuity of cancer care.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 36 (5)
Evaluation of the role of liver metastasectomy in the treatment of stage IV endometrial cancer
Baldwin XL, et al. J Gynecol Oncol. 2025 Feb;36:e79. https://doi.org/10.3802/jgo.2025.36.e79
- 1 January 2025
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 36 (5)
Open AccessEvaluation of the role of liver metastasectomy in the treatment of stage IV endometrial cancer
Baldwin XL, et al. J Gynecol Oncol. 2025 Feb;36:e79. https://doi.org/10.3802/jgo.2025.36.e79
- Open Access
- 18 December 2024
- Published by Oxford University Press (OUP) in JNCI Cancer Spectrum
- Vol. 9 (1)
Evaluating the intersection of climate vulnerability and cancer burden in North Carolina
Climate-related extreme weather events disrupt health-care systems and exacerbate health disparities, particularly affecting individuals diagnosed with cancer. This study explores the intersection of climate vulnerability and cancer burden in North Carolina (NC). Using county-level data from the US Climate Vulnerability Index (CVI) and the NC Department of Health and Human Services, we analyzed cancer incidence and mortality rates from 2017 to 2021. Our findings reveal a robust correlation between CVI percentiles and cancer mortality (r = 0.72). Counties with high area deprivation like Scotland, Robeson, and Halifax had the highest CVI percentiles of 0.68, 0.67, and 0.66, with respective cancer mortality rates of 193, 195, and 196 per 100 000 person-years. Correlations between CVI and cancer incidence were modest (r = 0.22). These results underscore the need for targeted public health interventions to mitigate climate-related health disparities. Future work could focus on exploring specific climate hazards and cancer outcomes to enhance preparedness and resilience in cancer care.
- 18 December 2024
- Published by Oxford University Press (OUP) in JNCI Cancer Spectrum
- Vol. 9 (1)
Open AccessEvaluating the intersection of climate vulnerability and cancer burden in North Carolina
Climate-related extreme weather events disrupt health-care systems and exacerbate health disparities, particularly affecting individuals diagnosed with cancer. This study explores the intersection of climate vulnerability and cancer burden in North Carolina (NC). Using county-level data from the US Climate Vulnerability Index (CVI) and the NC Department of Health and Human Services, we analyzed cancer incidence and mortality rates from 2017 to 2021. Our findings reveal a robust correlation between CVI percentiles and cancer mortality (r = 0.72). Counties with high area deprivation like Scotland, Robeson, and Halifax had the highest CVI percentiles of 0.68, 0.67, and 0.66, with respective cancer mortality rates of 193, 195, and 196 per 100 000 person-years. Correlations between CVI and cancer incidence were modest (r = 0.22). These results underscore the need for targeted public health interventions to mitigate climate-related health disparities. Future work could focus on exploring specific climate hazards and cancer outcomes to enhance preparedness and resilience in cancer care.
- 3 September 2024
- Published by Elsevier in Journal of Surgical Education
- Vol. 81 (11) , 1538-1552
Surgeon Perceptions and Variations in Surgical Morbidity and Mortality Conference: Report of a Survey from the American College of Surgeons Board of Governors
- 3 September 2024
- Published by Elsevier in Journal of Surgical Education
- Vol. 81 (11) , 1538-1552
Surgeon Perceptions and Variations in Surgical Morbidity and Mortality Conference: Report of a Survey from the American College of Surgeons Board of Governors
- 16 July 2024
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 33 (8) , 984-988
Estimating the Effects of Cancer Screening in Clinical Practice Settings: The Role of Selective Uptake and Suboptimal Adherence along the Cancer Screening Continuum
Randomized controlled trials (RCT) are the gold standard in determining efficacy of cancer screening tests. Yet, systematic differences between RCT and the general populations eligible for screening raise concerns about the generalizability and relevance of RCT findings to guide the development and dissemination of cancer screening programs. Observational studies from clinical practice settings have documented selective uptake in screening—i.e., variation across subgroups regarding who is screened and not screened—as well as suboptimal adherence to screening recommendations, including follow-up of positive findings with subsequent imaging studies and diagnostic invasive procedures. When the effectiveness of a screening intervention varies across subgroups, and there is selective uptake and suboptimal adherence to screening in clinical practice relative to that in the RCT, the effects of screening reported in RCTs are not expected to generalize to clinical practice settings. Understanding the impacts of selective uptake and suboptimal adherence on estimates of the effectiveness of cancer screening in clinical practice will generate evidence that can be used to inform future screening recommendations and enhance shared decision-making tools.
- 16 July 2024
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 33 (8) , 984-988
Estimating the Effects of Cancer Screening in Clinical Practice Settings: The Role of Selective Uptake and Suboptimal Adherence along the Cancer Screening Continuum
Randomized controlled trials (RCT) are the gold standard in determining efficacy of cancer screening tests. Yet, systematic differences between RCT and the general populations eligible for screening raise concerns about the generalizability and relevance of RCT findings to guide the development and dissemination of cancer screening programs. Observational studies from clinical practice settings have documented selective uptake in screening—i.e., variation across subgroups regarding who is screened and not screened—as well as suboptimal adherence to screening recommendations, including follow-up of positive findings with subsequent imaging studies and diagnostic invasive procedures. When the effectiveness of a screening intervention varies across subgroups, and there is selective uptake and suboptimal adherence to screening in clinical practice relative to that in the RCT, the effects of screening reported in RCTs are not expected to generalize to clinical practice settings. Understanding the impacts of selective uptake and suboptimal adherence on estimates of the effectiveness of cancer screening in clinical practice will generate evidence that can be used to inform future screening recommendations and enhance shared decision-making tools.